相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy
Jiang Li et al.
PLOS ONE (2007)
Increase in circulating Foxp3+CD4+CD25 high regulatory T cells in nasopharyngeal carcinoma patients
K-M Lau et al.
BRITISH JOURNAL OF CANCER (2007)
Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls
Felix Gronen et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma
Srikumar Sengupta et al.
CANCER RESEARCH (2006)
The BZLF1 homolog of an Epstein-Barr-related γ-herpesvirus is a frequent target of the CTL response in persistently infected rhesus macaques
Mark H. Fogg et al.
JOURNAL OF IMMUNOLOGY (2006)
Differential targeting and shifts in the immunodominance of Epstein-Barr virus-specific CD8 and CD4 T cell responses during acute and persistent infection
T Woodberry et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-hodgkin lymphoma
E Piriou et al.
BLOOD (2005)
Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma
KC Straathof et al.
JOURNAL OF IMMUNOLOGY (2005)
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes
KCM Straathof et al.
BLOOD (2005)
Novel method for detection of virus-specific CD4+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects
ER Piriou et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation
KS Voo et al.
CANCER RESEARCH (2005)
Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes
KS Voo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma
P Comoli et al.
ANNALS OF ONCOLOGY (2004)
Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma
N Heussinger et al.
JOURNAL OF PATHOLOGY (2004)
CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1
SP Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1
J Tellam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma
D Chua et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4+ T-helper 1 responses
A Leen et al.
JOURNAL OF VIROLOGY (2001)
The importance of exogenous antigen in priming the human CD8+ T cell response:: Lessons from the EBV nuclear antigen EBNA1
N Blake et al.
JOURNAL OF IMMUNOLOGY (2000)
CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells
SP Lee et al.
JOURNAL OF IMMUNOLOGY (2000)
Human CD4+ T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1
C Münz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
